PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
32957333 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | methylprednisolone | NA | unclassified | |
patient concerns: a 31-year-old male who was diagnosed as "myelodysplastic syndromes with excess blasts ii" (intermediate risk 2 of international prognostic scoring system) received human leukocyte antigen -matched sibling donor allogeneic hematopoietic stem cell transplantation. | |||||||
32957333 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | myelodysplastic syndromes | NA | methylprednisolone | NA | unclassified | |
in this study, oral fmt capsules from unrelated donor were used for the first time in the treatment of intestinal gvhd.patient concernsa 31-year-old male who was diagnosed as "myelodysplastic syndromes with excess blasts ii" (intermediate risk 2 of international prognostic scoring system) received human leukocyte antigen -matched sibling donor allogeneic hematopoietic stem cell transplantation. | |||||||
32957333 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | methylprednisolone | NA | unclassified | |
in this study, oral fmt capsules from unrelated donor were used for the first time in the treatment of intestinal gvhd.patient concernsa 31-year-old male who was diagnosed as "myelodysplastic syndromes with excess blasts ii" (intermediate risk 2 of international prognostic scoring system) received human leukocyte antigen -matched sibling donor allogeneic hematopoietic stem cell transplantation. | |||||||
34518095 | HLA MATCHED (HLA-MATCHED) | myelodysplastic syndromes | NA | amikacin | NA | negative | |
this 61-year-old female patient was diagnosed with myelodysplastic syndromes and underwent allogeneic hsct from an 8/8 hla-matched unrelated donor after reduced-intensity conditioning. | |||||||
10469028 | MHC (MHC) | bronchial hyperreactivity | NA | NA | NA | unclassified | |
to determine whether this was influenced by linkage disequilibrium within the mhc, 91 subjects with bronchial hyperreactivity and 85 control subjects were typed for class 2 and 3 alleles. | |||||||
8401680 | HLA (HLA) | recurrent miscarriage | NA | NA | NA | unclassified | |
hla frequency, hla sharing and immunotherapy in the management of recurrent miscarriage. | |||||||
8579756 | NA (NA) | recurrent miscarriage | NA | NA | NA | positive+negation | |
human leukocyte antigen dq alpha sharing is not increased in couples with recurrent miscarriage. | |||||||
8579756 | NA (NA) | recurrent miscarriage | NA | NA | NA | unclassified | |
problemthe results regarding human leukocyte antigen (hla) dq alpha allele sharing in recurrent miscarriage couples are conflicting. | |||||||
8579756 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | recurrent miscarriage | NA | NA | NA | unclassified | |
problemthe results regarding human leukocyte antigen (hla) dq alpha allele sharing in recurrent miscarriage couples are conflicting. | |||||||
9764359 | HLA-C (HLA-C) | recurrent miscarriage | NA | NA | NA | positive | |
we thus found it relevant to elucidate whether parental hla-c and -bw polymorphism play a role in recurrent miscarriage (rm). |
Copyright 2024